Back to Results
First PageMeta Content
Endocrine system / Thyroid disease / Thyroid cancer / Multiple endocrine neoplasia type 2 / Medullary thyroid cancer / Multiple endocrine neoplasia / RET proto-oncogene / Pheochromocytoma / Hyperparathyroidism / Medicine / Health / Endocrinology


PPMSAC Application 1152: Final Decision Analytic Protocol (DAP) to guide the assessment of genetic testing for hereditary mutations in the RET gene January 2012
Add to Reading List

Document Date: 2014-11-06 23:49:36

Open Document

File Size: 2,41 MB

Share Result on Facebook

City

Toledo / Adelaide / /

Company

Fleming / Cancer Genetics Diagnostic Laboratory / IVDs / INITIATION OF / /

Country

United States / Australia / /

Currency

USD / /

Event

FDA Phase / /

Facility

Institute of Medical / Cancer Genetics Diagnostic Laboratory / University of Adelaide / Royal College of Pathologists / /

IndustryTerm

clinical management algorithms / magnetic resonance imaging / adrenal imaging e.g. / adrenal imaging / clinical management / decision analytic protocol / imaging / diagnostic medical devices / diagnostic technologies / genetic testing protocol / adrenal imaging e.g. adrenal / health insurance / healthcare resources / genetic services / /

MedicalCondition

sporadic medullary thyroid carcinoma / incident neoplasm / hepatic tumours / hereditary mutations / seemingly unrelated syndrome / eye abnormalities / cognitive symptoms / thyroid carcinomas / hyperparathyroidism / hereditary disordersa / carcinoma / individual developing hyperparathyroidism / gastrointestinal ganglioneuromas / hereditary disorders / rare disorder / hyperparathyroidism 9144002863000Type / medullary thyroid carcinomas / infectious agent / von Hippel Lindau disease / ganglioneuromas / medullary thyroid carcinoma / cancer / disease / hereditary ie MEN2A / spontaneous medullary thyroid carcinoma / infective disease / congenital disorders / multiple endocrine neoplasia type II / tumour / thyroid carcinoma / Hirschsprung disease / medullary thyroid cancer / mucosal ganglioneuromas / diseases / osteoporosis / carcinomas / parathyroid disease / familial medullary thyroid cancer / infectious disease / thyroid nodule / distant metastases / sporadic and hereditary cases / disorders / gestational trophoblastic disease / tumours / /

MedicalTreatment

radiation therapy / chemotherapy / surgery / counselling / /

Organization

University of Adelaide / Royal College of Pathologists of Australasia / Institute of Medical and Veterinary Science / National Pathology Accreditation Advisory Council / Familial Cancer Unit / School of Population Health and Clinical Practice / Therapeutic Goods Administration / Australian government / Molecular Pathology Division / Veterinary Science / National Association of Testing Authorities / Medicare / Genetics Subcommittee / National Pathology Accreditation Advisory Committee / Royal College of Pathologists / MESP / Pathology Services Table Committee / Department of Health / Institute of Medical / Medical Services Advisory Committee / /

/

Position

general practitioner / Commonwealth Minister / Governor / Health Minister / Annual General / /

Product

thyroglobulin / glucagon / Fludrocortisone acetate / ACTH / testosterone / Hydrocortisone / MTC / RET / /

ProvinceOrState

South Australia / /

Region

South Australia / /

Technology

Alpha / radiation / 1 Management algorithm / decision analytic protocol / tomography / diagnostic tests / management algorithm / ultrasound / Final Decision Analytic Protocol / MRI / magnetic resonance imaging / Two clinical management algorithms / chemotherapy / genetic testing protocol / genotype / 2 Management algorithm / /

URL

http /

SocialTag